Does RIFAXIMIN Cause Therapy cessation? 334 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 334 reports of Therapy cessation have been filed in association with RIFAXIMIN (XIFAXAN). This represents 2.4% of all adverse event reports for RIFAXIMIN.
334
Reports of Therapy cessation with RIFAXIMIN
2.4%
of all RIFAXIMIN reports
29
Deaths
181
Hospitalizations
How Dangerous Is Therapy cessation From RIFAXIMIN?
Of the 334 reports, 29 (8.7%) resulted in death, 181 (54.2%) required hospitalization, and 3 (0.9%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIFAXIMIN. However, 334 reports have been filed with the FAERS database.
What Other Side Effects Does RIFAXIMIN Cause?
Death (3,687)
Hospitalisation (1,605)
Therapy interrupted (875)
Off label use (802)
Diarrhoea (709)
Ammonia increased (676)
Inability to afford medication (672)
Insurance issue (577)
Confusional state (530)
Hepatic cirrhosis (480)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which RIFAXIMIN Alternatives Have Lower Therapy cessation Risk?
RIFAXIMIN vs RILMENIDINE
RIFAXIMIN vs RILONACEPT
RIFAXIMIN vs RILPIVIRINE
RIFAXIMIN vs RILUZOLE
RIFAXIMIN vs RIMABOTULINUMTOXINB